Last updated on June 2018

Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)


Brief description of study

UX023-CL301 is a multicenter, randomized, open-label, Phase 3 study comparing the efficacy and safety of KRN23 with active control (oral phosphate/active vitamin D therapy) in children with XLH (aged 1 to ≤12 years) who have radiographic evidence of rickets, open epiphyses, and have received oral phosphate/active vitamin D therapy for ≥ 6-12 consecutive months prior to screening. Approximately 60 subjects will be randomized 1:1 to receive open-label KRN23 administered by subcutaneous injection or oral phosphate and active vitamin D therapy for a total of 64 weeks.

Clinical Study Identifier: NCT02915705

Contact Investigators or Research Sites near you

Start Over

Patient Advocacy

Children's Hospital Los Angeles
Los Angeles, CA United States

Patient Advocacy

UCSF
San Francisco, CA United States

Patient Advocacy

Indiana University School of Medicine
Indianapolis, IN United States

Patient Advocacy

Shriners Hospital For Children
Saint Louis, MO United States

Patient Advocacy

Vanderbilt University Medical Center
Nashville, TN United States

Patient Advocacy

Sydney Children's Hospital Network
Westmead, Australia

Patient Advocacy

Children's Hospital of Eastern Ontario (CHEO) Research Institute
Ottowa, ON Canada

Etienne Sochett

SickKids
Toronto, ON Canada

Patient Advocacy

Shriners Hospital for Children - Canada
Montreal, QC Canada

Henrik Christesen

ODense University Hospital
Odense C, Denmark

Jorg Semler

Children's Hospital University Cologne
Cologne, Germany

Klaus Mohnike

Universitaetsklinikum Magdeburg A. oe. R.-Otto-von-Guericke Universty
Magdeburg, Germany

Ciara McDonnell

Children's University Hospital
Dublin, Ireland

Maria Luisa Brandi

University of Florence
Florence, Italy

Stefano Mora

(IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)
Milan, Italy

Maria Luisa Bianchi

IRCCS Istituto Auxologico Italiano
Milan, Italy

Giampiero Baroncelli

U.O. Pediatria 1, AOUP
Pisa, Italy

Takashi Hamajima

Aichi Chidren's Medical Center
Obu, Japan

Patient Advocacy

Hyogo Prefectural Kobe Children's Hospital
Kobe, Japan

Patient Advocacy

Kanagawa Children's Medical Center
Yokohama, Japan

Patient Advocacy

Osaka University Hospital
Suita-shi, Japan

Patient Advocacy

Okayama Saiseikai General Hospital
Okayama, Japan

Patient Advocacy

Japan Community Healthcare Organization Osaka Hospital
Osaka, Japan

Patient Advocacy

National Center for Child Health and Development
Tokyo, Japan

Patient Advocacy

Seoul National University Hospital
Seoul, Korea, Republic of

Gabriel Martos-Moreno

Hospital Infantil Universitario Ni o Jes s
Madrid, Spain

Patient Advocacy

Karolinska Institutet and University Hospital
Stockholm, Sweden

Patient Advocacy

Birmingham Children's Hospital
Birmingham, United Kingdom

Raja Padidela

Royal Manchester Children's Hospital - University of Manchester
Manchester, United Kingdom